Myovant Sciences Ltd. Stock
Equities
MYOV
BMG637AM1024
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
David C. Marek
CEO | Chief Executive Officer | 59 | 21-01-03 |
Adele Gulfo
BRD | Director/Board Member | 61 | 19-12-26 |
Marianne Romeo
PRN | Corporate Officer/Principal | 56 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Adele Gulfo
BRD | Director/Board Member | 61 | 19-12-26 |
David C. Marek
CEO | Chief Executive Officer | 59 | 21-01-03 |
Director/Board Member | 59 | 22-10-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.11% | 0 M€ | 0.00% | - | |
0.08% | 0 M€ | 0.00% | - | |
0.06% | 1,487 M€ | +9.21% | - |
1st Jan change | Capi. | |
---|---|---|
+64.23% | 62.59B | |
-2.31% | 41.18B | |
+45.43% | 40.29B | |
-8.29% | 27.9B | |
+11.97% | 26.21B | |
-21.16% | 19.09B | |
+7.54% | 13.08B | |
+27.17% | 12.05B | |
+25.72% | 12.26B |